Analyst consensus rating
Tonix Pharmaceuticals Holding Analyst Rating: Strong Buy
Direct answer
Tonix Pharmaceuticals Holding's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $44.50.
Forecast evidence checked October 19, 2026.
Get free Tonix Pharmaceuticals Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.04
- Average price target
- $44.50
- High price target
- $65.00
- Low price target
- $22.00
- Low target gap
- +264.2%
- Target upside
- +636.8%
- High target gap
- +976.2%
- Target range width
- 711.9%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding has a verified Strong Buy consensus. The same dataset has an average price target of $44.50.
How far are Tonix Pharmaceuticals Holding's low and high targets from the recorded price?
The low target implies +264.2%, while the high target implies +976.2%.
How many analysts are included in Tonix Pharmaceuticals Holding's consensus?
The verified consensus includes 4 analysts.
How is Tonix Pharmaceuticals Holding's target upside or downside calculated?
The average target of $44.50 is divided by the recorded price of $6.04, then one is subtracted to produce +636.8%. This does not guarantee a future return.
When was Tonix Pharmaceuticals Holding's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.